Hot of the press IJROBP - The Red Journal: Role of SABR in oligometastatic head and neck cancer: a GORTEC randomized trial Full text here: doi.org/10.1016/j.ijro…

This year, the US will run a deficit of about 7.5% of GDP. If we don’t cut that to 3% of GDP, we’re likely to face a significant debt crisis in the next few years. This is not an issue that can wait. We need to do these cutbacks and adjustments while things are relatively

We are over $36 trillion in debt. We have a $2 trillion deficit. We are not at war with anyone. Why would we spend a record breaking $1 trillion on the military budget?

What if this was a drug ?🙂 🆕 NEJM | June 2025 🎯 CHALLENGE Trial: Structured exercise after adjuvant chemo in colon cancer 📦 RCT | n=889 | Median FU: 7.9 yrs 🟠 3-yr structured aerobic program vs health ed alone 📈 Primary Endpoint: Disease-Free Survival (DFS) 🔹 HR 0.72

Damn, I wasn't ready for how this would feel. We didn't have a camcorder, so there's no video of me with my mom. I dropped one of my favorite photos of us in midjourney as 'starting frame for an AI video' and wow... This is how she hugged me. I've rewatched it 50 times.

The older I get, the more I realize that it’s perfectly ok to live a life that looks confusing to others. Wake up early. Eat real foods. Go on long walks. Obsess over something. Pray. Be grateful. Read old books. Never gossip. Be loved by a few. Recipe for a good life.

ER doc here. Please take this advice: Do it today.

It’s funny that the worst punishments as a kid are the best rewards as an adult: • Go to bed early • Time alone in your room • Not allowed to go out • Eat dinner alone My 10-year-old self would never have believed how delightfully boring I’d become.

This is one of my favorite movie scenes of all time... It always hits me hard: "No I didn't rush the f*cking field, I wasn't there...I was in a bar having a drink with my future wife. That's why I'm not talking right now about some girl I saw at a bar 20 years ago. How I

Important work by Patrick Oh and team 👏 Relaxing lung V5 constraints can meaningfully improve heart & intermediate-dose lung metrics, especially with greater craniocaudal target extent with central components. Excited to see this move the field forward. #ASTRO25 #RadOnc

🔥 LUNAR trial: In oligometastatic hormone-sensitive #ProstateCancer, adding 2 cycles of 177Lu-PSMA 💥 ☢️ before SBRT ⬆️ doubled PFS (18 vs 7 mo, HR 0.32, p<0.001) with minimal added adverse events. 🚀 PSMA-RLT + SBRT = new frontier #ASTRO25 #RadOnc #NuclearMedicine ASTRO

As expected people resist letting go of dogma. Lets review the common examples people grasp at: 1. Nodal field size: cited as why GETUG01 was negative (S1/S2), then cited why RTOG 9413 was negative (L5/S1), then POP-RT positive (L4/L5), but definitive trial of RTOG 0924 (L4/L5)

Big news! 📣 We’re teaming up with City of Hope for the first-ever UCLA/COH Mock Orals course. Taking the April ABR oral exam? We’ve got your back. Master the format, calm the nerves, and let us support you! All virtual: 3/7/26 & 3/14/26 Stay tuned for registration info!

Adam B. Weiner, MD European Urology Oncology Anthony T. Nguyen, MD, PhD Daniel E Spratt Soumyajit Roy (Soum) The Lancet Oncology And in that large dataset, the rate of grade 3+ GU toxicity was 3.4%, and grade 3+ GI toxicity 2.2%. Again, with a longer interval from RT.

🔴Online now: Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised #prostatecancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial thelancet.com/journals/lanon…

#GU26 and #fengsymposium was a blast to see progress. Hoping it eventually moves away from San Fran 😁. Another red eye on the books back home. My observations from PCa sessions: - the field continues to push for over tx and many fail to recognize high risk dz is not high

John Christodouleas Agree: it begs the question of how many historical "in-field" recurrences were actually marginal. Information such as this highlight the importance of performing prospective clinical trials of ART. We have no idea what we're missing (literally, in this case) until we formally

Can we predict immunotherapy success by forecasting severe radiation-induced lymphopenia (RIL)? A pretreatment NSCLC nomogram shows only low RIL-risk patients benefit from adjuvant durvalumab, potentially enabling personalized RIL mitigation and optimized immunotherapy. Read it

NEJM posting about on-line adaptive radiotherapy is a #BigDeal. Thank you Deborah Citrin and Robert Timmerman MR-Linac Consortium Elekta

𝙳𝚊𝚟𝚒𝚍 𝙲𝚊𝚗𝚎𝚜 I respectfully disagree. There are numerous right and wrong decisions in many areas (flight paths and real time adjustments). The surge of autonomous agentic agents that can self train makes barriers shorter and shorter. AI will absolutely come for high cost, high resource